August 1, 2019
Joint Commission issues new Sentinel Event Alert on managing risks of direct oral anticoagulants
Editor's Note
In response to an increase in adverse events related to direct oral anticoagulants (DOACs), the Joint Commission, on July 31, issued a new Sentinel Event Alert on managing DOAC risks.
The alert:
- provides guidance for safe use and management of DOACs
- stresses understanding the risks, benefits, side effects, and reversal agents for all anticoagulants.
The alert has an accompanying infographic on “10 ways to be prepared to treat patients on direct oral anticoagulants (DOACs).”
Free Daily News
- Borescope inspections reveal widespread contamination in lumened surgical instruments
- Nursing workforce faces high turnover despite signs of recovery
- FDA issues early alerts for intravascular catheters
- Market volatility threatens hospitals’ liquidity as tariff-driven costs rise
- Study: CT scan radiation could drive 5% of future cancer cases
- New studies, surgical feats advance organ transplant medicine
- Commentary: Cyberattacks threaten financial survival of surgical practices
- Tariffs strain supply chains, split medical manufacturing community
- Study: Systemic gender bias embedded in surgical practice
- Literature review: Endoscope disinfection failures highlight need for stronger sterilization practices
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement